{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20694792", "DateCompleted": {"Year": "2010", "Month": "12", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s00210-010-0545-2"], "ArticleDate": [{"Year": "2010", "Month": "08", "Day": "08"}], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "382", "Issue": "3", "PubDate": {"Year": "2010", "Month": "Sep"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment.", "Pagination": {"StartPage": "287", "EndPage": "291", "MedlinePgn": "287-91"}, "Abstract": {"AbstractText": ["The purpose of this study is to investigate whether an oxygen/ozone (O(2)/O(3)) mixture protects the heart from acute myocardial infarction through local involvement of endothelial nitric oxide synthase (eNOS) and endothelial progenitor cells (EPCs). Male Sprague-Dawley rats were subject to 25-min occlusion and 2-h reperfusion of the left descending coronary artery. O(2)/O(3) mixture was insufflated i.p. 30 min prior to ischemia/reperfusion (I/R) procedure at doses of 100, 150, and 300 microg/kg. Myocardial infarct size (IS) measurement and myocardial immunohistochemistry for EPCs were done. For these latter cells, immunoreactivities for CD34, and CD117/c-kit were assessed within the infarcted tissue. Moreover, cardiac eNOS was monitored. I/R in rats treated with O(2) produced an IS as a percentage of the area at risk (IS/AR) equal to 51 +/- 5%. I/R in rats treated with the O(2)/O(3) mixture showed reduced IS (for example, IS/AR for 150 microg/kg O(2)/O(3) was 35 +/- 2.1%; P < 0.01 vs. O(2)). The O(2)/O(3) cardio-protection was paralleled by an increased number of immunopositive particles per area for CD34 and CD117/c-kit. The increase of these markers was associated with an increase of cardiac eNOS expression as assayed by immunohistochemistry. Interestingly, N5-(1-Iminoethyl)-L-ornithine dihydrochloride (L-NIO), a selective eNOS activity inhibitor (30 mg/kg s.c.), prior to O(2)/O(3) and I/R almost abolished the cardio-protection exerted by the O(2)/O(3) mixture. L-NIO also abolished the increase in immunostaining for CD-34 and CD117/c-kit as compared with the rats receiving O(2)/O(3) and I/R only. O(2)/O(3) mixture protects the heart from acute myocardial infarction through local increase of eNOS expression/activity and consequent EPCs recruitment."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Second University of Naples, Via Costantinopoli 16, Naples, Italy. clara.difilippo@unina2.it"}], "Identifier": [], "LastName": "Di Filippo", "ForeName": "Clara", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Luongo", "ForeName": "Margherita", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Marfella", "ForeName": "Raffaele", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ferraraccio", "ForeName": "Franca", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lettieri", "ForeName": "Biagio", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Capuano", "ForeName": "Annalisa", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rossi", "ForeName": "Francesco", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "D'Amico", "ForeName": "Michele", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "36889-13-1", "NameOfSubstance": "N(G)-iminoethylornithine"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "E524N2IXA3", "NameOfSubstance": "Ornithine"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Endothelial Cells"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Myocardial Infarction"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Myocardial Reperfusion Injury"}, {"QualifierName": ["drug effects", "genetics", "metabolism"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Ornithine"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Oxygen"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Stem Cells"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Atheroscler Thromb. 2009 Aug;16(4):319-26", "ArticleIdList": ["19672036"]}, {"Citation": "Blood. 2005 Jan 1;105(1):199-206", "ArticleIdList": ["15345590"]}, {"Citation": "Nat Med. 2001 Apr;7(4):430-6", "ArticleIdList": ["11283669"]}, {"Citation": "Basic Res Cardiol. 2008 Jan;103(1):69-77", "ArticleIdList": ["17999028"]}, {"Citation": "J Cell Physiol. 2009 May;219(2):235-42", "ArticleIdList": ["19115244"]}, {"Citation": "Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1236-41", "ArticleIdList": ["14656709"]}, {"Citation": "J Physiol Pharmacol. 2009 Dec;60(4):147-55", "ArticleIdList": ["20065509"]}, {"Citation": "Pharmacol Rep. 2008 Jan-Feb;60(1):119-26", "ArticleIdList": ["18276993"]}, {"Citation": "Cell Mol Biol (Noisy-le-grand). 2008 Oct 26;54(1):11-23", "ArticleIdList": ["18954547"]}, {"Citation": "Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H931-7", "ArticleIdList": ["12915384"]}, {"Citation": "Inflamm Res. 2008 Oct;57(10):445-9", "ArticleIdList": ["18827966"]}]}], "History": [{"Year": "2010", "Month": "7", "Day": "5"}, {"Year": "2010", "Month": "7", "Day": "23"}, {"Year": "2010", "Month": "8", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "8", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "12", "Day": "14", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20694792", "10.1007/s00210-010-0545-2"]}}], "PubmedBookArticle": []}